REDBIOTEC
Redbiotec is a private biotech company in Zurich-Schlieren. Founded in 2006 as a spin-off of ETH Zürich, the company has won several awards and is backed by experienced institutional and private investors. During its era as a vaccine innovator, Redbiotec has sold its CMV vaccine business to Pfizer in 2015 and also created an HSV-2 immunotherapy. Presently, Redbiotec is dedicated to developing bacteria-based gene therapies to treat cancer and genetic disorders. The proprietary bacteria platform accommodates large and diverse therapeutic cargos and is designed to overcome many delivery hurdles faced by other vehicles.
REDBIOTEC
Industry:
Biotechnology Pharmaceutical Therapeutics
Founded:
2006-11-11
Address:
Schlieren, Zurich, Switzerland
Country:
Switzerland
Website Url:
http://www.redbiotec.ch
Total Employee:
11+
Status:
Closed
Contact:
+41 44 200 23 20
Email Addresses:
[email protected]
Total Funding:
0
Technology used in webpage:
Viewport Meta IPhone / Mobile Compatible Google Analytics LetsEncrypt Apple Mobile Web Clips Icon Google Tag Manager WordPress Google Universal Analytics Wordpress Plugins Global Site Tag
Current Advisors List
Current Employees Featured
Founder
Investors List
Redalpine
Redalpine investment in Venture Round - Redbiotec
Official Site Inspections
http://www.redbiotec.ch
- Host name: srv127.tophost.ch
- IP address: 194.150.248.44
- Location: Switzerland
- Latitude: 47.1449
- Longitude: 8.1551
- Timezone: Europe/Zurich
